Contact HIV/AIDS
Info on HIV/AIDS:
206-205-7837
TTY: 206-296-4843
Toll-free: 800-678-1595
Administration:
206-296-4649
HIV/STD Testing
HIV/STD Hotline:
206-205-7837 or
Toll-free: 800-678-1595
11:00 am to 4:00 pm
Monday - Friday for
testing information, resources and referrals
|
|
HIV/AIDS Program
Bibliographies for October 2000
| 1. |
AIDS—No Time to
Spare: The Final Report to the President of the United States. Presidential
Advisory Council on HIV/AIDS, September 2000. |
| 2. |
Hecht FM, Chesney MA, et al. Does
HIV reporting by name deter testing? AIDS, 2000;14:1801-1808. |
| 3. |
Rugg DL, Heitgerd JL, et al. CDC
HIV prevention indicators: monitoring and evaluating HIV prevention
in the USA. AIDS, 2000;14:2003-2013. |
| 4. |
Nelson MK and Klinger RL. Personality
Disorders and HIV Diseases: The Borderline Patient. Focus,
August 2000;15(9):1-8. |
| 5. |
Nelson MK and Klinger RL. Personality
Disorders and HIV Diseases: The Borderline Patient. Focus,
August 2000;15(9):1-8. |
| 6. |
Hellinger FJ and Fleischman JA. Estimating the National Cost of Treating People with HIV Disease:
Patient, Payer, and Provider Data. JAIDS, 2000;24:182-188. |
| 7. |
Lombardi EL and van Servellen
G. Correcting Deficiencies in HIV/AIDS Care for Transgendered Individuals.J
Assn Nurses AIDS Care, September/October 2000;11(5):61-69. |
| 8. |
McQuiston C and Flaskerud JH. Sexual Prevention of HIV: A Model for Latinos. J Assn Nurses
AIDS Care, September/October 2000;11(5):70-79. |
| 9. |
Lee R. Health care problems
of lesbian, gay, bisexual, and transgender patients. West J
Med, June 2000;172:403-408. |
| 10. |
Nathanson N and Mathieson BJ. Biological Considerations in the Development of an HIV Vaccine.J
Inf Dis, August 2000;182:579-589. |
| 11. |
Rappaport C and Shade S. Gender
Differences in Viral Load Measurements: More questions, still no answers.Medical
Alert, 2000;1:6-7. |
| 12. |
Anastos K, Gange SJ, et al. Association
of Race and Gender with HIV-1 RNA Levels and Immunologic Progression. JAIDS, 2000;24:218-226. |
| 13. |
Anastos K. Re-examining Treatment
Recommendations for Women. BETA, Summer 2000:32-36. |
| 14. |
Linnehan MJ and Groce NE. Counseling
and Educational Interventions for Women with Genital HPV Infection.AIDS
Patient Care & STDs, 2000;14(8):439-445. |
| 15. |
Marrazzo JM. Genital HPV Infection
in Women Who Have Sex with Women: A Concern for Patients and Providers. AIDS Patient Care & STDs, 2000;14(8):447-451. |
| 16. |
Gross M, Holte SE, et al. Anal
Sex Among HIV-Seronegative Women at High Risk of HIV Exposure. JAIDS, 2000;24:393-398. |
| 17. |
Helfgott A, Eriksen N, et al. Vaginal infections in HIV-infected women. Am J Obstet Gynecol,
2000;183:347-355. |
| 18. |
Latka M, Gollub E, et al. Male-Condom
and Female-Condom Use Among Women After Counseling in a Risk-Reduction
Hierarchy for STD Prevention. Sex Trans Dis, September
2000;27(8):431-437. |
| 19. |
Grimes DA. Intrauterine device
and upper-genital-tract infection. Lancet, September 16,
2000;356:1013-1019. |
| 20. |
Gollub EL. The Female Condom: Tool for Women's Empowerment. AJPH, Sept. 2000;90(9):1377-81. |
| 21. |
Des Jarlais DC. Structural interventions to reduce HIV transmission among injecting drug users.AIDS, 2000;14(suppl 1):S41-S46.
|
| 22. |
Taussig JA, Weinstein B, et al. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS, 2000;14(suppl 1):S47-S51.
|
| 23. |
Hagan H and Thiede H. Changes in injection risk behavior associated with participation in the Seattle Needle-Exchange Program. J Urban Health, September 2000;77:369-382.
|
| 24. |
Burris S, Abrahamson D, and Rich JD. Physician Prescribing of Sterile Injection Equipment to Prevent HIV Infection: Time for Action. Ann Intern Med, 2000;133:218-226.
|
| 25. |
Kelly PAT. Does recreational ecstasy use cause long-term cognitive problems? West J Med, August 2000;173:129-130.
|
| 26. |
Hutin YJF, Sabin KM, et al. Multiple Modes of Hepatitis A Virus Transmission among Methamphetamine Users. Am J Epidemiol. 2000;152(2):186-192.
|
| 27. |
Kral AH, Lorvick J, and Edlin BR. Sex- and Drug-Related Risk Among Populations of Younger and Older Injection Drug Users in Adjacent Neighborhoods in San Francisco. JAIDS, 2000;24:162-167.
|
| 28. |
McLellan AT, Lewis DC, et al. Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation. JAMA, October 4, 2000;284(13):1689-1695.
|
| 29. |
Moss AR et al. Epidemiology and the Politics of Needle Exchange. (A forum of six articles dealing with Needle Exchange, epidemiology, politics, and health policies.) AJPH, Sept. 2000;90(9):1385-1396.
|
| 30. |
Newschaffer CJ, Cocroft J, et al. Prenatal Zidovudine Use and Congenital Anomalies in a Medicaid Population.JAIDS, 2000;24:249-256.
|
| 31. |
Stringer JSA, Rouse DJ, et al. Cost-Effective Use of Nevirapine to Prevent Vertical HIV Transmission in Sub-Saharan Africa. JAIDS, 2000;24:369-377.
|
| 32. |
Chantry CJ, Morrison P, et al. Effects of Lipolysis or Heat Treatment on HIV-1 Provirus in Breast Milk.JAIDS, 2000;24:325-329.
|
| 33. |
Pillay K, Coutsoudis A, et al. Cell-Free Virus in Breast Milk of HIV-1-Seropositive Women. JAIDS, 2000;24:330-336.
|
| 34. |
Gibb DM, Goodall RL, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet, September 9, 2000;356:904-907.
|
| 35. |
Committee on Pediatric AIDS. Identification and Care of HIV-Exposed and HIV-Infected Infants, Children, and Adolescents in Foster Care. Pediatrics, July 2000;106(1):149-153.
|
| 36. |
Birkhead GS, Chang HG, et al. Consented testing of newborns and childbearing women for HIV through a newborn metabolic screening program. Am J Obstet Gynecol, 2000;183:245-251.
|
| 37. |
Mofenson LM. Perinatal Exposure to Zidovudine—Benefits and Risks (editorial). NEJM, September 14, 2000;343(11):803-805.
|
| 38. |
Lipschultz SE, Easley KA, et al. Absence of Cardiac Toxicity of Zidovudine in Infants. NEJM, September 14, 2000;343(11):759-766.
|
Sexually Transmitted Diseases
|
| 39. |
Rothenberg RB, Wasserheit JN, et al. The Effect of Treating STD on the Transmission of HIV in Dually Infected Persons. Sex Trans Dis, August 2000;27(7):411-416.
|
| 40. |
Anzala AO, Simonsen JN, et al. Acute Sexually Transmitted Infections Increase HIV-1 Plasma Viremia, Increase Plasma Type 2 Cytokines, and Decrease CD4 Cell Counts. J Inf Dis, 2000;182:459-466.
|
| 41. |
Buchacz K, McFarland W, et al. Prevalence and Correlates of Herpes Simplex Virus Type 2 Infection in a Population-Based Survey of Young Women in Low-Income Neighborhoods of Northern California. Sex Trans Dis, August 2000;27(7):393-400.
|
| 42. |
Ruiz JD, Molitor F, et al. Prevalence of HIV infection, STD, and hepatitis and related risk behavior in young women living in low-income neighborhoods of northern California. West J Med, June 2000;172:368-373.
|
| 43. |
Pimenta J, Catchpole M, et al. Screening for genital chlamydial infection. BMJ, September 9, 2000;321:629-631.
|
| 44. |
Newton EAC and Kuder JM. A Model of the Transmission and Control of Genital Herpes. Sex Trans Dis, August 2000;27(7):363-370.
|
| 45. |
Drake S, Taylor S, et al. Improving the care of patients with genital herpes. BMJ, September 9, 2000;321:619-623.
|
| 46. |
Peterman TA, Lin LS, et al. Does Measured Behavior Reflect STD Risk? An analysis of data from a randomized controlled behavioral intervention study. Sex Trans Dis, September 2000;27(8):446-451.
|
Men Who Have Sex With Men
|
| 47. |
Wohlfeiler D. Structural and environmental HIV prevention for gay and bisexual men. AIDS, 2000;14(suppl 1):S52-S56.
|
| 48. |
Icard LD and Goodwin L. HIV Among African-American Men Who Have Sex with Men. Focus, July 2000;15(8):1-8.
|
| 49. |
Remis RS, Dufour A, et al. Association of Hepatitis B Virus Infection with Other Sexually Transmitted Infections in Homosexual Men. Am J Public Health, October 2000;90(10):1570-1574.
|
| 50. |
Waldo CR, McFarland W, et al. Very Young Gay and Bisexual Men are at Risk for HIV Infection: The San Francisco Bay Area Young Men’s Survey II. JAIDS, 2000;24:168-174.
|
| 51. |
Koblin BA, Torian LV, et al. High prevalence of HIV infection among young men who have sex with men in New York City. AIDS, 2000;14:1793-1800.
|
| 52. |
Collins C, Morin SF, et al. Designing
Primary Prevention for People Living with HIV (monograph).AIDS
Research Institute, University of California, San Francisco. March
2000. |
| 53. |
Shriver MD, Everett C, and Morin
SF. Structural interventions to encourage primary HIV prevention
among people living with HIV. AIDS, 2000;14(suppl 1):S57-S62. |
| 54. |
Missed Opportunities
for Prevention of Tuberculosis Among Persons with HIV Infection—Selected
Locations, United States, 1996-1997. MMWR, August 4, 2000;49(30):685-687. |
| 55. |
Lansky A, Nakashima AK, et al. Risk Behaviors Related to Heterosexual Transmission from HIV-Infected
Persons. Sex Trans Dis, September 2000;27(8):483-489. |
| 56 |
Van Dis J. Against the Grain:
Living with HIV in Rural South Dakota. JAMA, October 4,
2000;284(13):1706-1707. |
| 57 |
Turner BJ, Cunningham WE, et al. Delayed Medical Care After Diagnosis in a US National Probability
Sample of Persons Infected with HIV. Arch Intern Med, September 25, 2000;160(17):2614-2622. |
| 58. |
Rotheram-Borus MJ. Expanding
the range of interventions to reduce HIV among adolescents. AIDS,
2000;14(suppl1):S33-S40. |
| 59. |
Kennedy MG, Mizuno Y, et al. Increasing
condom use among adolescents with coalition-based social marketing. AIDS, 2000;14:1809-1818. |
| 60. |
Ellen JM, Lane MA, and McCright
J. Are adolescents being screened for STD? West J Med,
August 2000;173:109-114. |
| 61. |
Santelli JS, Lindberg LD, et al. Adolescent Sexual Behavior: Estimates and Trends from Four Nationally
Representative Surveys. Fam Plan Perspec, 2000;32(4):156-165
& 194. |
| 62 |
Cluster of HIV-Infected
Adolescents and Young Adults—Mississippi, 1999. MMWR, September 29, 2000;49(38):861-864. |
| 63 |
Youth and HIV/AIDS
2000: A New American Agenda. Office of National AIDS Policy.
44-page report. |
| 64. |
Craven DE and Nunes DP. Managing Hepatitis C Infection in HIV-Positive Patients. AIDS Clinical Care, September 2000;12(9):75-76.
|
| 65. |
Dieterich DT. Chronic Hepatitis C: Update on Diagnosis and Treatment. Consultant, August 2000:1590-1596.
|
| 66. |
Wong JB, McQuillan GM, et al. Estimating Future Hepatitis C Morbidity, Mortality, and Costs in the United States. Am J Public Health, October 2000;90(10):1562-1569.
|
Anti-Retroviral Treatment
|
| 67. |
Mirken B. AIDS Treatment Improves Survival: Answering the "AIDS Denialists." AIDS Treatment News, September 8, 2000;350:2-8.
|
| 68. |
Schwarcz SK, Hsu LC, et al. Impact of Protease Inhibitors and Other Antiretroviral Treatments on AIDS Survival in San Francisco, California, 1987-1996. Am J Epidemiol, 2000;152(2):178-185.
|
| 69. |
Bart PA, Rizzardi GP, et al. Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy. AIDS, 2000;14(13):1887-1897.
|
| 70. |
Colven R, Harrington RD, et al. Retroviral Rebound Syndrome after Cessation of Suppressive Antiretroviral Therapy in Three Patients with Chronic HIV Infection. Ann Intern Med, September 19, 2000;133(6):430-434.
|
| 71. |
Kilby JM, Goepfert PA, et al. Recurrence of the Acute HIV Syndrome after Interruption of Antiretroviral Therapy in a Patient with Chronic HIV Infection: A Case Report. AIDS, September 19, 2000;133(6):435-438.
|
American Journal of Public Health
|
1023 The Public Health Challenges of the HIV Epidemic J. Levi
1024 Children and Older Persons: AIDS' Unseen Victims J. Knodel and M. VanLandingham
1026 A Change in Approach to Prenatal HIV Screening N. Kass
Commentaries
1029 HIV Prevention Research: Accomplishments and Challenges for the Third Decade of AIDS J. D. Auerbach and T. J. Coates
1033 HIV: Challenging the Health Care Delivery System J. Levi and J. Kates
1037 Tracking the HIV Epidemic: Current Issues, Future Challenges P. L. Fleming, P. M. Wortley, J. M. Karon, K. M. DeCock, and R. S. Janssen
Public Health Matters
1042 Culture, Sexuality, and Women's Agency in the Prevention of HIV/AIDS in Southern Africa I. Susser and Z. Stein
1049 The Social Geography of AIDS and Hepatitis Risk: Qualitative Approaches for Assessing Local Differences in Sterile-Syringe Access Among Injection Drug Users M. Singer, T. Stopka, C. Siano, K. Springer, G. Barton, K. Khoshnood, R. Heimer, and A. Gorry de Puga
Articles
1059 Perceived Unmet Need for Oral Treatment Among a National Population of HIV-Positive Medical Patients: Social and Clinical Correlates M. Marcus, J. R. Freed, I. D. Coulter, C. Der-Martirosian, W. Cunningham, R. Andersen, I. Garcia, D. A. Schneider, W. R. Maas, S. A. Bozzette, and M. F. Shapiro
1064 Economic Deprivation and AIDS Incidence in Massachusetts S. Zierler, N. Krieger, Y. Tang, W. Coady, E. Siegfried, A. DeMaria, and J. Auerbach
1074 HIV-Infected Parents and Their Children in the United States M. A. Schuster, D. E. Kanouse, S. C. Morton, S. A. Bozzette, A. Miu, G. B. Scott, and M. F. Shapiro
1082 Bridging the Gap Between the Science and Service of HIV Prevention: Transferring Effective Research-Based HIV Prevention Interventions to Community AIDS Service Providers J. A. Kelly, A. M. Somlai, W. J. DiFranceisco, L. L. Otto-Salaj, T. L. McAuliffe, K. L. Hackl, T. G. Heckman, D. R. Holtgrave, and D. Rompa
1089 HIV Testing Among the General US Population and Persons at Increased Risk: Information From National Surveys, 19871996 J. E. Anderson, J. W. Carey, and S. Taveras
1096 A Participant Observation Study Using Actors at 30 Publicly Funded HIV Counseling and Testing Sites in Pennsylvania A. J. Silvestre, M. B. Gehl, J. Encandela, and G. Schelzel
1100 HIV Transmission and the Cost-Effectiveness of Methadone Maintenance G. S. Zaric, P. G. Barnett, and M. L. Brandeau
1112 Behavioral Risk Reduction in a Declining HIV Epidemic: Injection Drug Users in New York City, 19901997D. C. Des Jarlais, T. Perlis, S. R. Friedman, T. Chapman, J. Kwok, R. Rockwell, D. Paone, J. Milliken, and E. Monterroso
1117 Frequent Use of Lubricants for Anal Sex Among Men Who Have Sex With Men: The HIV Prevention Potential of a Microbicidal Gel A. Carballo-Diéguez, Z. Stein, H. Sáez, C. Dolezal, L. Nieves-Rosa, and F. Díaz
1135 Preaching to the Choir: Preference for Female-Controlled Methods of HIV and Sexually Transmitted Disease PreventionS. T. Murphy, L. C. Miller, J. Moore, and L. F. Clark
1138 Delays in Seeking HIV Care Due to Competing Caregiver Responsibilities M. D. Stein, S. Crystal, W. E. Cunningham, A. Ananthanarayanan, R. M. Andersen, B. J. Turner, S. Zierler, S. Morton, M. H. Katz, S. A. Bozzette, M. F. Shapiro, M. A. Schuster
|
|
|
